INT007

INT007 is an orally administered film formulation of an erectile dysfunction drug developed by IntelGenx as a generic/bioequivalent alternative to an existing reference product. In a pharmacokinetic crossover study in healthy male volunteers, INT007 demonstrated bioequivalence to the reference erectile dysfunction product based on maximum concentration (Cmax) and area under the curve (AUC), indicating similar systemic exposure. The formulation is designed to provide a convenient oral delivery form while maintaining equivalent efficacy and safety to the branded comparator; detailed target, molecular identity, and mechanism of action have not been publicly disclosed.